Skip to main navigation
  • Company
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Work
  • Our Pipeline
    • ACG-801 (Farber Disease)
    • ACG-701 (Melioidosis)
    • ACG-701 (Cystic Fibrosis)
  • Patient Info
    • Farber Disease
    • Melioidosis
    • Cystic Fibrosis
    • Contact Us
  • Investors
  • Investor Relations
    • Investors and Media
    • Annual Meeting Materials
    • Analyst Coverage
    • Press Releases
    • Investor Events
    • Corporate Governance
    • Stock Information
    • Financial Reports
    • SEC Filings
    • Investor Information
    • E-mail Alerts
×

Investors

MainNavMenu

  • Investors
  • Special Meeting of Stockholders
  • Press Releases
  • Investor Events
  • Corporate Governance
    • Management & Directors
    • Committee Composition
    • conduct
    • guidelines
  • Stock Information
    • Historical Price Lookup
    • Investment Calculator
    • Stock Chart
    • Stock Quote
  • SEC Filings
  • Investor Information

Contact us

Please direct all questions regarding Aceragen to:

Aceragen, Inc.
15 TW Alexander Drive
Durham, NC 27709

info@aceragen.com

Investor Tools

Print Page
RSS Feeds
E-mail Alerts

Management & Directors

CorporateMenu

  • Highlights
  • Management & Directors
  • Committee Composition
  • Guidelines
  • Conduct

MANAGEMENT

  • John Taylor
    Chief Executive Officer
  • John J. Kirby
    Chief Financial Officer
  • Carl Kraus
    Chief Medical Officer
  • Bryant D. Lim
    Chief Business Officer and General Counsel
  • Daniel Salain
    Chief Operating Officer
  • Andy Jordan
    Chief Strategy Officer

DIRECTORS

  • Cristina Csimma, Pharm. D., M.H.P.
  • Michael Dougherty
  • James Geraghty
  • Maxine Gowen, PhD
  • Vincent Milano
    Chair of the Board
  • John Taylor
    Chief Executive Officer
  • Ron Wooten

MainNavMenu

  • Investors
  • Special Meeting of Stockholders
  • Press Releases
  • Investor Events
  • Corporate Governance
    • Management & Directors
    • Committee Composition
    • conduct
    • guidelines
  • Stock Information
    • Historical Price Lookup
    • Investment Calculator
    • Stock Chart
    • Stock Quote
  • SEC Filings
  • Investor Information

Contact us

Please direct all questions regarding Aceragen to:

Aceragen, Inc.
15 TW Alexander Drive
Durham, NC 27709

info@aceragen.com

Investor Tools

Print Page
RSS Feeds
E-mail Alerts

© 2023 Aceragen, Inc. All rights reserved.

  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Share